Fecal microbiota, live-jslm ( REBYOTA ® [RBL]) demonstrates a favorable safety profile and treatment effectiveness against recurrent Clostridioides difficile infection (rCDI) in patients with and ...

Later breakfast was associated with older age, certain physical and psychological illnesses, and increased mortality.

Routine pelvic MRI reveals subclinical perianal disease in 1 in 5 patients newly diagnosed with CD, which could lead to earlier treatment.

A palliative care consultation is associated with reduced odds of unplanned 30-day and 90-day readmission among those with decompensated cirrhosis.

GERD was linked to risk for tinnitus, Meniere disease, vestibular dysfunction, and sensorineural hearing loss.

Most women with hyperemesis gravidarum reported "major impacts" on their social life, daily chores, eating, work, and sleep.

A computer vision model showed high agreement with standard instruments like the Simple Endoscopic Score for Crohn's Disease.

Intecept Pharmaceuticals has decided to voluntarily withdraw Ocaliva (obeticholic acid) from the US market, following a request from the FDA.

Salt substitute use was at or below 5.4% among US adults from 2003 to 2020, with use up to 10.5% in those with treated hypertension.

The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of ...

Patients with cancer may have medical debt in collections that persists for years after their diagnosis, despite high rates of insurance coverage.

Egrifta WR, a new concentrated formulation (F8) of tesamorelin, is now available for HIV-related lipodystrophy.